An interventional study of Movement Improvisation Skill-building and Adaptive Dance Intervention in Stroke, sponsored by Chinese University of Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-05-15.
Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Health services research
The project will investigate the effects of a novel 12-week Movement Improvisation Skill-building and Adaptive Dance Intervention (MDI) on participation, balance, mobility, balance confidence, psychological well-being, and health-related quality of life in survivors with hemiparesis.
A 2-arm, assessor-blinded, randomised controlled trial will be conducted. Individuals who are 18-80 years old and have hemiparesis after a first-ever/recurrent ischaemic/haemorrhagic stroke will be recruited. The participants will be randomly allocated to the control group receiving usual care or the intervention group receiving MDI and usual care. Based on Bandura's principles of Self-efficacy and Outcome Expectation, MDI is an online/hybrid intervention aimed to assist survivors in developing body awareness, body sense, movement improvisational skills, and abilities in creating mental images of movements and balance during their transition of care from the acute settings to home. The outcomes will be assessed before the intervention, immediately post-intervention, and 3 and 6 months post-intervention.
Exclusion Criteria:
The MDI is a hybrid in-person/online intervention aimed at developing body awareness, body sense, movement improvisational skills, and the ability to create mental images of movements and balance among stroke survivors with hemiparesis.
Other: Movement Improvisation Skill-building and Adaptive Dance Intervention
Usual care
The MDI is a hybrid in-person/online intervention aimed at developing body awareness, body sense, movement improvisational skills, and abilities in creating mental images of movements and balance among stroke survivors with hemiparesis.
Change in the level of participation in daily and social activities
The Reintegration to Normal Living Index (Chinese version) will be used to assess participants' participation in daily and social activities.
Time frame: From baseline to immediately, 3 months and 6 months post-intervention
Change in the level of balancing ability
The 14-item Mini- Balance Evaluation Systems Test will be used to measure participants' anticipatory postural adjustments, reactive postural control, sensory orientation, and dynamic gait.
Time frame: From baseline to immediately, 3 months and 6 months post-intervention
Change in the level of mobility
The 6-minute walk test (MWT) will be performed according to the American Thoracic Society guidelines.
Time frame: From baseline to immediately, 3 months and 6 months post-intervention
Change in the level of balance confidence
The Activities-specific Balance Confidence Scale (Chinese version) will be used to assess participants' confidence in balance when performing 16 daily functional activities.
Time frame: From baseline to immediately, 3 months and 6 months post-intervention
Change in the level of psychological well-being
Participants' emotional well-being will be measured by the Hospital Anxiety and Depression Scale (Chinese version).
Time frame: From baseline to immediately, 3 months and 6 months post-intervention
Change in the level of health-related quality of life
The EuroQoL 5 Dimension (Chinese version) will be used. It contains 5 dimensions (mobility, self-care, usual activities, pain/ discomfort, anxiety/depression),
Time frame: From baseline to immediately, 3 months and 6 months post-intervention
Plan to share: No — The information will be provided on request.
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chinese University of Hong Kong